EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access

Pilot Trial of SDX/d-MPH Adult ADHD Examining Effects Throughout the Day

Lenard A Adler, Dayeon Cho, Terry Leon, Mariane Guschwan, Caleb A Massimi, Deepti Anbarasan

Psychopharmacology Bulletin · 2025

DOI: 10.64719/pb.4551 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Psychopharmacology Bulletin, 2025. Verfasst von Lenard A Adler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Adler, MD, Departments of Psychiatry and Child and Adolescent Psychiatry, NYU Grossman School of Medicine, New York, NY, USA. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Methylphenidate, Central Nervous System Stimulants, Dextroamphetamine. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To examine the effects of Serdexmethylphenidate/dexmethylphenidate (SDX/d-MPH) on ADHD symptoms throughout the day in adults with DSM-5 ADHD.

Method

This was a 6-week pilot study that included 3 weeks of open label treatment with SDX/d-MPH (39.2/7.8 mg/day to 52.3/10.4 mg/day in clinical titration) after completion of a one-week screening period and a two-week observation period in seventeen adults with ADHD. Two subjects were discontinued from the trial, one for being placebo-responder and another for exhibiting blood pressure lability during the observation period. Of the remaining 15 subjects, one dropped out after one week on 39.2/7.8 mg/day, while all others completed the trial. All fifteen participants were included in the data analyses.

Results

There were substantial effects of SDX/d-MPH on all clinical measures, including investigator symptom scores (AISRS); self-report (ASRS) scores, time-sensitive ADHD (TASS) scores throughout the day, impairment (CGI) and executive function scores (BRIEF-A) and measures of medication smoothness (AMSES). SDX/d-MPH was generally well tolerated.

Conclusions

This pilot study is the first systematic treatment effect trial data for SDX/d-MPH in adults with DSM-5 ADHD. The data preliminarily supports the clinical efficacy of DSM/d-MPH in adult ADHD and its ability to ameliorate symptoms throughout the day.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Attention Deficit Disorder with HyperactivityMethylphenidateCentral Nervous System StimulantsDextroamphetamineHumansPilot ProjectsAdultMaleFemaleMiddle AgedTreatment OutcomeYoung AdultDrug Combinations

Stichwörter der Autor:innen

AISRSASRSBRIEF-ACGITASSadult ADHDserdexmethylphenidate

Substanzen

MethylphenidateCentral Nervous System StimulantsDrug CombinationsDextroamphetamine

Autor:innen und Institutionen

  • Adler, MD, Departments of Psychiatry and Child and Adolescent Psychiatry, NYU Grossman School of Medicine, New York, NY, USA.
  • Cho, MA, Departments of Psychiatry, NYU Grossman School of Medicine, New York, NY, USA.
  • Leon, RN, Departments of Psychiatry, NYU Grossman School of Medicine, New York, NY, USA.
  • Guschwan, MD, Departments of Psychiatry, NYU Grossman School of Medicine, New York, NY, USA.
  • Massimi, BA, Departments of Psychiatry, NYU Grossman School of Medicine; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Anbarasan, MD, Departments of Psychiatry, NYU Grossman School of Medicine, New York, NY, USA.

Zitieren

APA

Adler, L. A., Cho, D., Leon, T., Guschwan, M., Massimi, C. A., & Anbarasan, D. (2025). Pilot Trial of SDX/d-MPH Adult ADHD Examining Effects Throughout the Day. Psychopharmacology Bulletin. https://doi.org/10.64719/pb.4551

Vancouver

Adler LA, Cho D, Leon T, Guschwan M, Massimi CA, Anbarasan D. Pilot Trial of SDX/d-MPH Adult ADHD Examining Effects Throughout the Day. Psychopharmacology Bulletin. 2025. doi:10.64719/pb.4551

BibTeX
@article{Adler2025,
  author = {Adler, Lenard A and Cho, Dayeon and Leon, Terry and Guschwan, Mariane and Massimi, Caleb A and Anbarasan, Deepti},
  title = {Pilot Trial of SDX/d-MPH Adult ADHD Examining Effects Throughout the Day},
  journal = {Psychopharmacology Bulletin},
  year = {2025},
  doi = {10.64719/pb.4551}
}
Kostenlos starten →